touchENDOCRINOLOGY were delighted to speak with Prof. Hiddo Lambers Heerspink to hear more about the highly anticipated results of DAPA-CKD, investigating dapagliflozin in patients with chronic kidney disease with or without type 2 diabetes.
Disclosures: Prof. Lambers Heerspink discloses the following: Grant Funding and Consultancy from AstraZeneca, Boehringer Ingelheim and AbbVie, Steering committee member for Bayer and Chinook, Advisory Board for Mundipharma and Merck, Advisory Board and Speaker for Mitsubishi Tanabe, Steering committee member and Advisory Board for Janssen, Steering committee member for Gilead and CSL Pharma and Consultancy for Retrophin and Novo Nordisk.
Support: Interview and filming supported by Touch Medical Media.
Filmed as a highlight of the European Association for the Study of Diabetes (EASD) 2020.
Share this Video
Related Videos In Diabetes
Sacha Uelmen: National Standards for Diabetes Self-Management Education and Support
National Standards for Diabetes Self-Management Education and Support (DSMES) is a crucial element of care for patients with diabetes and those at risk for developing the disease. It was a pleasure to talk to Sacha Uelmen (Director of Diabetes Education & Prevention Programs, Association of Diabetes Care & Education Specialists). She outlines the support and […]
Part 1. Bitter Sweet: The Inspiration
Bitter Sweet: The Highs, The Lows, Hypers and Hypos of Living with Type 1 Diabetes is a groundbreaking new book of poetry on living with type 1 diabetes. In this video, author Duke Al and artist Dr Sarah Ali talk about their inspiration for writing the book, the artwork and how their unique collaboration came […]
Part 2. Bitter Sweet: From ‘Hidden Hypos’ to ‘Perfect’
Bitter Sweet: The Highs, The Lows, Hypers and Hypos of Living with Type 1 Diabetes is a groundbreaking new book of poetry on living with type 1 diabetes. In this video, author Duke Al talks about selected poems from the book and how their messages may help people living with type 1 diabetes, their friends […]
Journal articles and more to your inbox
Get the latest clinical insights from touchENDOCRINOLOGYSign me up!